Search the Newsreel

Oppenheimer & Co. Inc. Reduces Holdings in UnitedHealth Group Incorporated $UNH

Oppenheimer & Co. Inc. recently reduced its stake in UnitedHealth Group Incorporated by 8.0% in the second quarter, selling 2,570 shares and holding 29,503 shares valued at $12.26 million. Despite this, other institutional investors increased their positions, and UnitedHealth Group reported strong earnings, exceeding …

SWS Partners Makes New Investment in Guardant Health, Inc. $GH

SWS Partners has acquired a new stake in Guardant Health, Inc. (NASDAQ:GH), purchasing 74,582 shares valued at approximately $11.19 million, making it their 9th largest position. While institutional investors collectively own 92.6% of the company, several insiders have recently sold shares totaling over $106 …

Oppenheimer Asset Management Inc. Purchases 27,774 Shares of UnitedHealth Group Incorporated $UNH

Oppenheimer Asset Management Inc. significantly increased its stake in UnitedHealth Group Incorporated by 38.9% in the second quarter, acquiring an additional 27,774 shares to reach a total holding of 99,195 shares valued at $41.2 million. This move comes as UnitedHealth reported strong quarterly earnings …

Walleye Capital LLC Invests $11.65 Million in Omada Health, Inc. $OMDA

Walleye Capital LLC has invested $11.65 million in Omada Health, Inc. by acquiring 530,670 shares, representing approximately a 0.89% stake. This investment follows strong quarterly earnings from Omada Health, which surpassed revenue and EPS expectations. Despite positive analyst sentiment and a "Moderate Buy" consensus, …

Everett Harris & Co. CA Takes $2.14 Million Position in Cardinal Health, Inc. $CAH

Everett Harris & Co. CA has acquired a new position in Cardinal Health, Inc. (NYSE:CAH), purchasing 8,993 shares valued at approximately $2.14 million during the second quarter. Other institutional investors also adjusted their holdings in CAH. The article also provides details on Cardinal Health's …

LifeStance Health Group (NASDAQ:LFST) Rating Increased to Strong-Buy at Wall Street Zen

Wall Street Zen has upgraded LifeStance Health Group (NASDAQ:LFST) from "buy" to "strong-buy" after the company exceeded Q2 earnings and revenue expectations. Despite this upgrade and a "Moderate Buy" consensus from other analysts, insiders have recently sold a significant amount of shares. The stock …

Clover Health Investments: Real Turnaround, But Already Priced In (NASDAQ:CLOV)

45,236 Shares in AMN Healthcare Services Inc $AMN Acquired by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. recently acquired 45,236 shares of AMN Healthcare Services Inc. (NYSE:AMN) valued at approximately $1.46 million, making them one of many institutional investors who collectively own 99.23% of the company. AMN Healthcare reported strong quarterly earnings, beating analyst estimates for both …

Handelsbanken Fonder AB Increases Stock Position in Healthcare Realty Trust Incorporated $HR

BrightSpring Health Services (NASDAQ:BTSG) Upgraded at Wall Street Zen

Viemed Healthcare (NASDAQ:VMD) Lowered to "Buy" Rating by Wall Street Zen

Medi Assist Healthcare Services’ Q4 PAT jumps 51%, operating revenue rises 23%

LifeStance Health director Teresa DeLuca sells $249,993 in shares By Investing.com

LifeStance Health Group director Teresa DeLuca sold 20,441 shares of the company's common stock for $249,993 on August 13, 2026, with the shares trading near their 52-week high after a significant gain. Despite this sale, management has been actively buying back shares, though InvestingPro's …

Universal Health Realty Income Trust (NYSE:UHT) Share Price Crosses Above Two Hundred Day Moving Average - What's Next?

Tenet Healthcare (NYSE:THC) Lowered to "Buy" Rating by Wall Street Zen

Wall Street Zen downgraded Tenet Healthcare (NYSE:THC) from a "strong-buy" to a "buy" rating, despite the broader analyst consensus remaining a "Moderate Buy" with an average price target of $273. The company recently reported strong quarterly earnings of $6.12 per share, exceeding estimates, with …

Wall Street Zen Upgrades Harrow (NASDAQ:HROW) to "Hold"

Wall Street Zen has upgraded Harrow (NASDAQ:HROW) from "sell" to "hold," though overall analyst sentiment remains a "Moderate Buy" with a target of $69.43. This comes as Harrow reported a quarterly loss that missed estimates despite slightly exceeding revenue expectations. Institutional investors hold a …

Fractyl Health (NASDAQ:GUTS) Downgraded by Wall Street Zen to Sell

Fractyl Health (NASDAQ:GUTS) was downgraded from "hold" to "sell" by Wall Street Zen, despite a broader analyst consensus of "Moderate Buy" with a $5.12 target price. The company reported better-than-expected quarterly EPS of -$0.12, and insiders as well as institutional investors have recently increased …

Hims & Hers Health (NYSE:HIMS) Upgraded to Hold at Wall Street Zen

Aveanna Healthcare (NASDAQ:AVAH) Stock Rating Lowered by Wall Street Zen

Nephrocare Health Services Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

LifeStance Health Surpasses Q2 Earnings Expectations Driven by Clinician Growth

LifeStance Health significantly exceeded Q2 earnings expectations, reporting $435.4 million in revenue and an adjusted EPS of $0.11, driven by a 26.1% year-over-year growth and improved operational efficiency. The company raised its full-year guidance for both revenue and EBITDA, reflecting strong management confidence. This …

Zepp Health (ZEPP): Point72 and Steven Cohen exit with 0% reported stake

Point72 Asset Management, along with Point72 Capital Advisors and Steven A. Cohen, has reported a 0% beneficial ownership stake in Zepp Health Corp (ZEPP) as of June 30, 2026. This amended Schedule 13G/A filing indicates their complete exit from the company's Class A ordinary …

Aimei Health Technology Co., Ltd Revenue Breakdown – NASDAQ:AFJK

This article provides a revenue breakdown for Aimei Health Technology Co., Ltd (NASDAQ:AFJK) on TradingView. It offers an overview of the company's financials, including statements, statistics, dividends, earnings, and segments. The page also indicates that segment and regional performance data are available by source …

Aveanna Healthcare (AVAH) Stock Climbs On Higher Guidance And Cash Flow

Diversified Healthcare Trust (DHC) Narrows Loss As Fair Value Narrative Stays Higher

OSCR Stock Hits 5-Year High: Oscar Sees 'Healthy Tailwinds' In 2026 On Potential Upside To Guidance

HIMS Stock Plummets After Wall Street Downgrade, Price Target Cuts Following 'Disappointing' Q4 Report

Polar Asset Management (IXHL) reports 7.0% beneficial stake via 900,000 warrants

Polar Asset Management Partners Inc. has disclosed a 7.0% beneficial ownership stake in Incannex Healthcare Inc. (IXHL), totaling 900,000 shares. These shares are issuable upon the exercise of warrants and are held by Polar Multi-Strategy Master Fund, for which Polar acts as an investment …

OPKO Health Raises $125 Million in Additional Royalty-Backed Notes Under Amended HCR Agreement

OPKO Health has secured an additional $125 million in senior secured notes by amending its 2024 Note Purchase Agreement with HCR Injection SPV to enhance liquidity. These royalty-backed notes mature in 2044 and bear interest based on 3-month SOFR plus 7.5%, with payments primarily …

Key Highlights from Astrana Health's Q2 Earnings Call

AdaptHealth Corp. (AHCO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of AdaptHealth Corp. (NASDAQ: AHCO) purchasers following a significant drop in share price. The investigation stems from AdaptHealth's Q2 2026 earnings report, which showed revenue and adjusted EBITDA well below expectations, a GAAP …

Hims & Hers Finds A GLP-1 Hedge? HIMS Stock Rallies As RFK Jr. Signals Peptide Clearances

Enterprise value to revenue forward of Redco Healthy Living Company Limited – HKEX:2370

Agilon Health Inc (AGL) Stock Up 9.0% but GF Value Says Overvalued -- GF Score: 71/100

Agilon Health Inc (AGL) saw its stock rise by 9.0% to $96.90, but GuruFocus's GF Value indicates the stock is overvalued by 6.2% compared to its intrinsic value of $91.24. Despite a strong GF Score of 71/100, driven by good growth and valuation ranks, …

A Look at Aveanna Healthcare Holdings Inc (AVAH) After 9.2% Gain -- GF Value $5.20 vs Price $12.32

Aveanna Healthcare Holdings Inc (AVAH) recently saw a 9.2% stock gain, pushing its price to $12.32. However, GuruFocus estimates its intrinsic value (GF Value™) at $5.20, indicating significant overvaluation. The stock has an "Above Average" GF Score™ of 63/100, but is flagged for weak …

Top Optimi Health (OPTH) Competitors 2026

This article analyzes Optimi Health (OPTH) against its main competitors in the pharmaceuticals industry: Rafael (RFL), ImmuCell (ICCC), Cognition Therapeutics (CGTX), PolyPid (PYPD), and RF Acquisition Corp II (RFAI). The comparison is based on factors such as profitability, valuation, earnings, analyst recommendations, institutional ownership, …